Cargando…
Kinetics of Oncolytic Reovirus T3D Replication and Growth Pattern in Mesenchymal Stem Cells
OBJECTIVE: Currently, application of oncolytic-virus in cancer treatment of clinical trials are growing. Oncolytic-reovirus is an attractive anti-cancer therapeutic agent for clinical testing. Many studies used mesenchymal stem cells (MSCs) as a carrier cell to enhance the delivery and quality of tr...
Autores principales: | Banijamali, Razieh Sadat, Soleimanjahi, Hoorieh, Soudi, Sara, Karimi, Hesam, Abdoli, Asghar, Seyed Khorrami, Seyed Mahmood, Zandi, Keivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947011/ https://www.ncbi.nlm.nih.gov/pubmed/31863653 http://dx.doi.org/10.22074/cellj.2020.6686 |
Ejemplares similares
-
Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer
por: Karimi, Hesam, et al.
Publicado: (2020) -
MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice
por: Seyed-Khorrami, Seyed-Mahmood, et al.
Publicado: (2021) -
Reconstruction of H(3)N(2) influenza virus based virosome in-vitro
por: Abdoli, Asghar, et al.
Publicado: (2013) -
Determining Influenza Virus Shedding at Different Time
Points in Madin-Darby Canine Kidney Cell Line
por: Abdoli, Asghar, et al.
Publicado: (2013) -
Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
por: Shirmohammadi, Masoumeh, et al.
Publicado: (2021)